{"ModuleTitle": "Company Description", "CompanyName": "SIGA Technologies Inc.", "Symbol": "SIGA", "Address": "31 EAST 62ND STREET, NEW YORK, New York, 10065, United States of America", "Phone": "212-672-9100", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "SIGA Technologies, Inc. is referred to throughout this report as \"SIGA,\" \"the\r\nCompany,\" \"we\" or \"us.\"\r\n \r\nWe are a commercial-stage pharmaceutical company focused on the health security\r\nand infectious disease markets. Health security comprises countermeasures for\r\nbiological, chemical, radiological and nuclear attacks (biodefense market),\r\nvaccines and therapies for emerging infectious diseases, and health\r\npreparedness. Our lead product is an oral formulation of TPOXX\u00ae (\"oral TPOXX\u00ae\"),\r\nan antiviral drug for the treatment of human smallpox disease caused by variola\r\nvirus.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f05%2f0001010086-20-000006.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Daniel J. Luckshire", "title": "Chief Financial Officer, Secretary & Executive VP"}, {"name": "Dennis E. Hruby", "title": "Chief Scientific Officer & Vice President"}, {"name": "Herb Vloedman", "title": "Chief Information Officer"}, {"name": "Phillip Louis Gomez", "title": "Chief Executive Officer & Director"}, {"name": "Tove C. Bolken", "title": "Senior VP-Operations & Chief Supply Chain Officer"}], "Number_of_employees": [], "Subsidiaries": ["NO INFO"]}